Experts explore strategies to support shared decision-making in the treatment of patients with tardive dyskinesia, ...

Tardive Dyskinesia TD as a neurological disorder resulting in involuntary repetitive movement disorder as a disease of brain Neurology due to dopamine problems. What have studies said the role ...

"Be cognizant of the risk of [tardive dyskinesia] of every drug that's being used," advises Winoa Tse, MD, when prescribing antipsychotic agents. Dr. Tse, based at the Icahn School of Medicine in ...

Winona Tse, MD, professor of neurology at the Icahn School of Medicine in New York City, discusses some of the theories about how tardive dyskinesia develops in different patients. (2:07) ...

TD Awareness Week is an opportunity to increase knowledge about tardive dyskinesia, an often misunderstood and stigmatized condition. Here are some ideas for advocacy. Tardive dyskinesia (TD ...

Neurocrine Biosciences shares new data supporting Ingrezza's effectiveness in older adults with tardive dyskinesia. Read more ...

[MUSIC PLAYING] SPEAKER: The involuntary facial grimacing and slow, writhing body movements of tardive dyskinesia can be hard to live with. They might make you feel anxious, depressed, or worried ...

The FDA has approved Neurocrine Bioscience’s Ingrezza, the first ever licensed treatment for tardive dyskinesia or TD. The condition is characterised by uncontrollable movement of the body or ...